Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

An 11-year-old girl with Kawasaki disease experienced hair loss that improved after treatment.

Fahr syndrome causes brain calcification and is managed by treating symptoms and underlying issues.

DSDs are birth conditions causing unusual sex development, managed with personalized care and sometimes surgery, but still lack a standard treatment approach.

Alopecia universalis may be linked to Down syndrome due to genes on chromosome 21.

Majoon Ushba and Marham Gulabi effectively treat dermatophytosis.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

A new mutation in the Connexin 26 gene was found in a patient with KID syndrome, expanding the known disorders linked to this gene.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

The laser treatment effectively and safely improved keratosis pilaris.

Calcium supplements improved bone deformities but not skin papules or hair loss.

Darier-White disease causes skin and nail issues, starts around age 20, worsens until 40-50, and has poor treatment options.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

A woman with leprosy improved after stopping dapsone and getting treatment for a severe skin reaction and nail changes.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

A 15-year-old boy's skin and hair condition worsened due to improper treatment, leading to severe health issues.

The treatment for alopecia areata with diphenylcyclopropenone was unsuccessful.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Dupilumab improves eczema in Netherton Syndrome but not ichthyosis linearis circumflexa.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

The twins' condition is unique and doesn't match any known syndromes.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

The manual helps doctors quickly diagnose and manage skin diseases without lab tests.